A sign is posted in front of the 23andMe headquarters on February 01, 2024 in Sunnyvale, California. Genetic testing company 23andMe, once valued at $6 billion, is facing the possibility of delisting from NASDAQ as the company navigates numerous class action lawsuits.
California A-G urges 23andMe users to delete genetic data amid potential bankruptcy "I remind Californians to consider invoking their rights and directing 23andMe to delete their data and destroy any samples of genetic material held by the company,” California's A-G said.